Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group

Pediatric Critical Care Medicine

Volumn 13, Issue 5, 2012, Pages

  Fleming, Geoffrey M ^a   Walters, Scott ^b   Goldstein, Stuart L ^c   Alexander, Steven R ^d   Baum, Michelle A ^e   Blowey, Douglas L ^f   Bunchman, Timothy E ^g   Chua, Annabelle N ^h   Fletcher, Sarah A ⁱ   Flores, Francisco X ^j   Fortenberry, James D ^k   Hackbarth, Richard ^l   McBryde, Kevin ^m   Somers, Michael J G ^e   Symons, Jordan M ⁿ   Brophy, Patrick D ^o  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^m NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁿ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF IOWA   (United States)

more..

Author keywords

continuous renal replacement therapy; detoxification; inborn error of metabolism; intermittent hemodialysis; tumor lysis syndrome

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DETOXIFICATION; DIFFUSION; DRUG TOXICITY; HEMODIALYSIS; HUMAN; INBORN ERROR OF METABOLISM; INFANT; LENGTH OF STAY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; THERMODYNAMICS; TUMOR LYSIS SYNDROME;

ADOLESCENT; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DRUG TOXICITY; HEMODIALYSIS SOLUTIONS; HUMANS; INFANT; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; ODDS RATIO; REGISTRIES; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; TUMOR LYSIS SYNDROME;

EID: 84866423725     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31824fbd76     Document Type: Article

References (30)

1. Goldstein SL, Somers MJ, Brophy PD, et al: The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: Design, development and data assessed. Int J Artif Organs 2004; 27:9-14
2. Symons JM, Chua AN, Somers MJ, et al: Demographic characteristics of pediatric continuous renal replacement therapy: A report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007; 2:732-738
3. Brophy PD, Somers MJ, Baum MA, et al: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005; 20:1416-1421
4. Hackbarth R, Bunchman TE, Chua AN, et al: The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: A report from the PPCRRT registry. Int J Artif Organs 2007; 30:1116-1121
5. Sutherland SM, Zappitelli M, Alexander SR, et al: Fluid overload and mortality in children receiving continuous renal replacement therapy: The prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010; 55:316-325
6. Flores FX, Brophy PD, Symons JM, et al: Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 2008; 23:625-630
7. Goldstein SL, Somers MJ, Baum MA, et al: Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67:653-658
8. Choi KA, Lee JE, Kim YG, et al: Effcacy of continuous venovenous hemofltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Ann Hematol 2009; 88:639-645
9. Donn SM, Swartz RD, Thoene JG: Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyper-ammonemia in an anuric newborn infant. J Pediatr 1979; 95:67-70
10. Falk MC, Knight J F, Roy LP, et al: Continuous venovenous haemofltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 1994; 8:330-333
11. Feinfeld DA, Rosenberg JW, Winchester JF: Three controversial issues in extracorporeal toxin removal. Semin Dial 2006; 19:358-362
12. Jouvet P, Poggi F, Rabier D, et al: Continuous venovenous haemodiafltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis 1997; 20:463-472
13. Lai YC, Huang H P, Tsai IJ, et al: High-volume continuous venovenous hemofltration as an effective therapy for acute management of inborn errors of metabolism in young children. Blood Purif 2007; 25:303-308
14. Picca S, Dionisi-Vici C, Abeni D, et al: Extracorporeal dialysis in neonatal hyperam-monemia: Modalities and prognostic indicators. Pediatr Nephrol 2001; 16:862-867
15. Rutledge SL, Havens PL, Haymond MW, et al: Neonatal hemodialysis: Effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 1990; 116:125-128
16. Saccente SL, Kohaut EC, Berkow RL: Prevention of tumor lysis syndrome using continuous veno-venous hemofltration. Pediatr Nephrol 1995; 9:569-573
17. Arbeiter AK, Kranz B, Wingen AM, et al: Continuous venovenous haemodialy-sis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010; 25:1257-1265
18. Westrope C, Morris K, Burford D, et al: Continuous hemofltration in the control of neonatal hyperammonemia: A 10-year experience. Pediatr Nephrol 2010; 25:1725-1730
19. Wiegand C, Thompson T, Bock GH, et al: The management of life-threatening hyperammo-nemia: A comparison of several therapeutic modalities. J Pediatr 1980; 96:142-144
20. Schaefer F, Straube E, Oh J, et al: Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999; 14:910-918
21. McBryde KD, Kershaw DB, Bunchman TE, et al: Renal replacement therapy in the treatment of confrmed or suspected inborn errors of metabolism. J Pediatr 2006; 148:770-778
22. Parakininkas D, Greenbaum LA: Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 2004; 5:269-274
23. dePont: Extracorporeal treatment of intoxications. Curr Opin Crit Care 2007; 13:668-673
24. Holubek WJ, Hoffman RS, Goldfarb DS, et al: Use of hemodialysis and hemoperfu-sion in poisoned patients. Kidney Int 2008; 74:1327-1334
25. Kim Z, Goldfarb DS: Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract 2010; 115:c1-c6
26. Goodman JW, Goldfarb DS: The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 2006; 19:402-407
27. Pui CH, Mahmoud HH, Wiley JM, et al: Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol 2001; 19:697-704
28. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
29. Schwartz GJ, Brion L P, Spitzer A: The use of plasma creatinine concentration for estimating glomerular fltration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34:571-590
30. Goldstein SL, Currier H, Graf Cd, et al: Outcome in children receiving continuous venovenous hemofltration. Pediatrics 2001; 107:1309-1312